Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-05-13 16:16:23 ET · period of report 2026-05-11 · accession 0001822629-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 16:16 | 2026-05-11 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | S - Sale | $77.57 | -55.0K | 349.9K | -14% | -$4.27M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-11 | S | D | 55,000 | $77.57 | 349,889 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $76.21 to $80.38. The price reported above reflects the weighted average sales price. |